SCHEMBL7083232

SCHEMBL7083232

CCOP(=O)(OCC)C(=Cc1cc(OC)c(O)c(OC)c1)P(=O)(OCC)OCC

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 3/20 0.63
HMGCR P04035 3/20 0.63
KMT2A Q03164 4/20 0.47
MAPT P10636 3/20 0.47
GAA P10253 3/20 0.47
CYP3A4 P08684 3/20 0.44
CYP1A2 P05177 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2B6 P20813 2/20 0.44
CYP2D6 P10635 1/20 0.44
LMNA P02545 3/20 0.44
POLB P06746 2/20 0.44
PKM P14618 1/20 0.43
PTGS1 P23219 1/20 0.43
PTGS2 P35354 1/20 0.43
ALOX5 P09917 1/20 0.43
ABL1 P00519 1/20 0.41
BCR P11274 1/20 0.41
MEN1 O00255 3/20 0.41
EGFR P00533 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19403372 0.81 HMGCR (0.61) NR1I2HMGCRPTGS1ABL1BCR
SCHEMBL12270021 0.81 LMNA (0.47) NR1I2HMGCRKMT2AMAPTGAA
SCHEMBL7522505 0.79 KMT2A (0.55) KMT2AMAPTGAACYP3A4CYP1A2
SCHEMBL7079812 0.79 HMGCR (0.63) NR1I2HMGCRKMT2AMAPTGAA
SCHEMBL678403 0.78 HMGCR (1.00) NR1I2HMGCRKMT2AMAPTGAA
SCHEMBL7759881 0.77 NR1I2 (0.54) NR1I2HMGCRKMT2AMAPTLMNA
SCHEMBL7078823 0.75 HMGCR (0.75) NR1I2HMGCRKMT2AMAPTGAA
SCHEMBL7080863 0.75 HMGCR (0.59) NR1I2HMGCRKMT2AMAPTCYP3A4
SCHEMBL12270023 0.75 NR1I2 (0.69) NR1I2HMGCRKMT2AMAPTCYP3A4
SCHEMBL6061410 0.74 POLB (0.48) KMT2AMAPTGAACYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1326618-A2 USE OF ARYL-SUBSTITUTED 1,1-DIPHOSPHONATES FOR THE TREATMENT OF BONE DISEASES Ilex Oncology Research S.A. (CH) 2003-07-16 EP claimed
WO-2002011704-A2 USE OF ARYL-SUBSTITUTED 1,1-DIPHOSPHONATES FOR THE TREATMENT OF BONE DISEASES SYMPHAR S.A. (CH) 2002-02-14 WO claimed
EP-0845991-B1 USE OF PHENOL SUBSTITUTED DIPHOSPHONATES AS ANTINEOPLASTIC AGENTS SYMPHAR SA (CH) 2002-02-06 EP claimed
EP-0845991-A2 USE OF PHENOL SUBSTITUTED DIPHOSPHONATES AS ANTINEOPLASTIC AGENTS SYMPHAR S.A. (CH) 1998-06-10 EP claimed
WO-1997004785-A1 USE OF PHENOL SUBSTITUTED DIPHOSPHONATES AS ANTINEOPLASTIC AGENTS SYMPHAR S.A. (CH) 1997-02-13 WO claimed